25 Best Online Psychology Degree Programs Heading Into 2024

In This Article:

In this article, we will be looking at the 25 best online psychology degree programs heading into 2024. If you want to skip our detailed analysis, you can go directly to the 5 Best Online Psychology Degree Programs Heading Into 2024.

Global Mental Health Industry: An Overview

According to a report by IMARC, the global mental health market was valued at $435.2 billion in 2023. The market has been estimated to reach $567.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 2.9%. You can also check out: 15 Highest Paying Countries for Psychologists.

Rising awareness regarding mental health issues is encouraging more people to seek help which is the primary driving factor for the mental health market. Many online platforms and mobile applications have emerged to support the mental health of individuals. On October 5, Reuters reported that Headway raised $125 million in series C funding which led to the company being valued at $1 billion. Headway is a New York-based startup that connects patients with therapists and psychiatrists. The company currently has 26,000 service providers and 19 insurance plans to ensure optimal service delivery to patients.

Governments, especially in developing countries, have recently allocated substantial investments towards enhancing mental health infrastructure and implementing comprehensive programs. The increased government awareness is offering a positive market outlook during the forecast period. On June 7, Reuters reported that the European Commission has allocated $1.3 billion for mental health initiatives. The initiatives will be implemented across 27 European Union member states. The EU member states are to make mental health a pillar of their health policy as well. The EU is ambitious to make access to mental healthcare and treatment more affordable and accessible. You can also check out: 25 Countries With The Worst Healthcare System.

Major Players in the Mental Health Industry

Compass Pathways PLC (NASDAQ:CMPS) is a prominent name in the mental health industry. Companies in the mental health industry are focused on research to cater to the needs of patients affected by the mental health epidemic. On December 6, Compass Pathways PLC (NASDAQ:CMPS) announced that it had published a paper in JAMA Psychiatry journal regarding a potential treatment for treatment-resistant bipolar type II disorder. The publication is based on findings from a study funded by Compass Pathways PLC (NASDAQ:CMPS) conducted in Baltimore. The findings suggest that a single 25mg dose of COMP360 psilocybin treatment significantly reduced the bipolar II depression symptoms in patients.